While I have an upcoming post titled "Made in the USA", in which you can learn everything you ever wanted to know about manufacturing pill bags in the United States of America, I figured I should first do a post about LIVING in the USA, based up on this article that a friend forwarded me recently. Looks as though Benlysta wasn't welcomed with open arms in the UK as it was here in the US.
It appears that Nice, the National Institute for Health and Clinical Excellence, and also the Scottish Medicines Consortium, has rejected Glaxo-Smith Kline's Benlysta, thus denying patients access to the drug. The reason? As Nice chief executive, Sir Andrew Dillon says, "...the evidence considered did not persuade the committee that belimumab (Benlysta) provided enough health benefit for patients in view of how much the NHS would need to pay for it compared to standard care, as the cost of the drug in relation to how well it works is very high," said Sir Andrew in a statement.